Clinical trials in Hochheim Am Main – page 121

Innovative research focusing on Gaucher disease and Niemann-Pick disease, exploring new therapeutic approaches for these challenging genetic conditions. Studies aim to evaluate novel treatments for improving neurological symptoms and overall patient outcomes.

• Gaucher Disease TYPE 3 Treatment
• Niemann-Pick Disease Management
• Genetic Disease Therapies

Clinical investigations evaluating venglustat and nizubaglustat's effectiveness in managing disease progression.

Research centered on treating Mucopolysaccharidosis Type II (Hunter Syndrome) and Pompe disease, with multiple studies investigating innovative enzyme replacement therapies and novel drug combinations.

• Hunter Syndrome Treatment
• Infantile-onset Pompe Disease
• Late-onset Pompe Disease

Evaluation of treatments like JR-141 and cipaglucosidase alfa for improved patient outcomes.

Studies focused on preventing respiratory syncytial virus infections in older adults, with particular attention to vaccine development and immune response assessment.

• RSV Prevention
• Vaccine Development
• Immune Response Studies

Investigation of revaccination strategies and long-term protection against respiratory infections.